Max Healthcare Institute Ltd Q1 FY27 Earnings Analysis
Published 31 May 2026 | Healthcare Services | Market Cap: ₹1.0L Cr
Price
₹973
Market Cap
₹1.0L Cr
P/E Ratio
70.0
Revenue Rank
Margin Rank
Earnings Summary
- Phased commissioning of 20% additional brownfield capacity across Mohali, Nanavati (Mumbai), and Max Smart (Delhi) completed; full operationalization expected in next 2-3 months. - Max Healthcare expects significant operating leverage as recently added 20-25% brownfield capacity and upcoming greenfield projects ramp up over next 2-3 quarters to FY27.
📊 Revenue & Sales Performance
Rank 3- Phased commissioning of 20% additional brownfield capacity across Mohali, Nanavati (Mumbai), and Max Smart (Delhi) completed; full operationalization expected in next 2-3 months. - Additional 10% capacity to come from 500-bed greenfield hospital in Gurgaon, targeted for commissioning by end of the year. - Brownfield bed additions expected to ramp up EBITDA contribution meaningfully over next 2 quarters as occupancy rises. - Network gross revenue grew 16% YoY to INR 10,538 crore in FY26; operating EBITDA up 14% YoY. - Oncology revenue impacted by discontinuation of select high-value chemotherapy drugs; oncology share expected to stabilize around 21-22%, with other specialties expected to fill growth gap. - Occupancy levels remain strong (>75%) with phased bed rollouts to continue, supporting steady revenue and EBITDA growth. - New acquisitions like Kalinga Hospital to provide growth platforms in new regions (Eastern India). - Focus on ramping up recently commissioned capacities and integrating new facilities for sustained growth.
📈 Profitability & Margins
Rank 3- Max Healthcare expects significant operating leverage as recently added 20-25% brownfield capacity and upcoming greenfield projects ramp up over next 2-3 quarters to FY27. - The 500-bed greenfield hospital in Gurgaon is targeted for commissioning by end of FY27, expected to break even within first year. - New acquisitions like Kalinga Hospital (already EBITDA positive at INR 10 crore) and expansion in Lucknow, Dwarka, Noida are anticipated to contribute meaningfully to revenue and EBITDA growth. - The company has sustained 8-16% revenue growth and 8-14% operating EBITDA growth in recent quarters/years. - Profit after Tax (PAT) grew 22% in FY26, reflecting robust profitability. - Continued ramp-up and integration of newly commissioned beds and new facilities should support steady earnings growth and EPS expansion. - No significant regulatory or approval delays expected for pipeline projects, supporting timely execution and earnings contribution.
🏗️ Capital Expenditure Plans
Yes- The Board has approved an investment of INR 1,400 crore for constructing a 700-bed greenfield hospital at Shaheed Path, Lucknow. - Expansion projects underway include: - Max Lucknow capacity increase from 426 to 570 beds over next 2 quarters. - 500-bed facility at Sector 56 Gurgaon, commissioning targeted by end of the year. - 100 beds at Max Nagpur, expected commissioning by FY28. - 400 beds at Zirakpur, Mohali, on schedule for FY28. - 260 beds at Max Dwarka, building plan submission underway, expected 24 months to complete. - 200 beds at Max Vaishali, awaiting building plan approvals, 24 months expected post-approval. - 400 beds at Max Patparganj, D-wall construction started, expected commissioning by FY29. - Ongoing phased commissioning of over 20% additional brownfield capacity across hospitals. - Acquisition and expansion plans for Kalinga Hospital (250 beds) in Bhubaneswar.
💰 Fundraising & Capital Structure
No information- The transcript provided from Max Healthcare Institute Limited's Q4 & FY’26 earnings call does not mention any current or planned fundraising through debt or equity. - There is no indication of new debt issuance or equity raising activities discussed in the management commentary or Q&A sections. - The company notes strong free cash flow generation (INR 1,541 crore in FY26 after interest and taxes) and significant internal capital deployment towards expansion projects. - Net debt has decreased from INR 2,166 crore to INR 1,908 crore, showing a healthy deleveraging trend. - Management appears focused on phased expansion funded via internal accruals rather than external fundraising at this time.
📋 Order Book & Pipeline
No information- Max Healthcare has multiple ongoing and planned expansion projects with phased commissioning timelines. - Current expansion includes nearly 20% additional brownfield capacity added network-wide. - Specific projects and timelines: - Max Lucknow: Capacity increasing from 426 to 570 beds in next 2 quarters. - Sector 56 Gurgaon: 500 beds, commissioning targeted by end of FY 2026. - Max Nagpur: 100 beds, expected commissioning by FY 2028. - Zirakpur, Mohali: 400 beds, structural work ongoing, commissioning in FY 2028. - Max Dwarka: 260 beds, building plan underway, 24 months to complete. - Max Vaishali: 200 beds, pending building approvals, expected 24 months post approvals. - Max Patparganj: 400 beds, construction started, commissioning by FY 2029. - Shaheed Path Greenfield Hospital, Lucknow: 700 beds, INR 1,400 crore investment approved; phased build over ~3 years. - Overall strategy involves phased operationalization to manage ramp-up and occupancy efficiently.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Max Healthcare Institute Ltd Q1 FY27 results?
- Phased commissioning of 20% additional brownfield capacity across Mohali, Nanavati (Mumbai), and Max Smart (Delhi) completed; full operationalization expected in next 2-3 months. - Max Healthcare expects significant operating leverage as recently added 20-25% brownfield capacity and upcoming greenfield projects ramp up over next 2-3 quarters to FY27.
What is Max Healthcare Institute Ltd share price analysis?
Max Healthcare Institute Ltd currently shows a below-average growth signal. The stock trades at a P/E of 70.0 with a market cap of ₹102,200. Investors should review the full earnings analysis for detailed insights.
Is Max Healthcare Institute Ltd planning capital expenditure?
- The Board has approved an investment of INR 1,400 crore for constructing a 700-bed greenfield hospital at Shaheed Path, Lucknow.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
